Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion

2026-02-09 | original

read original get Ornacyte → more articles

Eli Lilly has struck a deal to buy genetic-medicine biotechnology company Orna Therapeutics for up to $2.4 billion in cash.

Explore topics: billion billion cash biotechnology biotechnology company buy genetic